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a  b  s  t  r  a  c  t
Background and objective: Vascularity evaluation on breast dynamic contrast-enhanced mag-
netic resonance imaging (DCE-MRI) has a potential diagnostic value, but it represents a
time  consuming procedure, affected by intra- and inter-observer variability. This study tests
the  application of a recently published method to reproducibly quantify breast vascularity,
and evaluates if the vascular volume of cancer-bearing breast, calculated from automatic
vascular maps (AVMs), may correlate with pathologic tumor response after neoadjuvant
chemotherapy (NAC).
Methods: Twenty-four patients with unilateral locally advanced breast cancer underwent
DCE-MRI before and after NAC, 8 responders and 16 non-responders. A validated algorithm,
based on multiscale 3D Hessian matrix analysis, provided AVMs and allowed the calculation
of  vessel volume before the initiation and after the last NAC cycle for each breast. For can-
cer  bearing breast, the difference in vascular volume before and after NAC was compared
in  responders and non-responders using the Wilcoxon two-sample test. A radiologist eval-
uated the vascularity on the subtracted images (first enhanced minus unenhanced), before
and after treatment, assigning a vascular score for each breast, according to the number of
vessels with length ≥30 mm and maximal transverse diameter ≥2 mm.  The same evalua-
tion  was repeated with the support of the simultaneous visualization of the AVMs. The two
evaluations were compared in terms of mean number of vessels and mean vascular score
per  breast, in responders and non-responders, by use of Wilcoxon two sample test. For allthe  analysis, the statistical significance level was set at 0.05.
Results: For breasts harboring the cancer, evidence of a difference in vascular volume before
and after NAC for responders (median = 1.71 cc) and non-responders (median = 0.41 cc) wasfound (p = 0.003). A significant difference was also found in the number of vessels (p = 0.03)
and vascular score (p = 0.02) before or after NAC, according to the evaluation supported by
the  AVMs.
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Conclusions: The encouraging, although preliminary, results of this study suggest the use
of  AVMs as new biomarker to evaluate the pathologic response after NAC, but also sup-
port  their application in other breast DCE-MRI vessel analysis that are waiting for a reliable
quantification method.
















































a.  Description  of  purpose
olid tumors rely on blood vessels to obtain necessary nutri-
nt and oxygen, and new vessels also offer path way for tumor
xpansion. Therefore, the assessment of tumor vascularity
ay provide useful information to characterize underlying
alignancy and monitor vascular abnormalities [1]. In the
ast decade, microvessel density represented the most com-
only used prognostic indicator for tumor vascularization in
 wide range of cancers, although its quantification remained
nreliable because of the lack of sufficient morphological and
unctional information of blood vessels, and it could be only
ssessed after the surgical resection of the primary tumor [1].
 better alternative to study tumor vasculature may be derived
rom non-invasive imaging techniques, such as contrast-
nhanced computed tomography (CT), magnetic resonance
maging (MRI) and dynamic contrast-enhanced magnetic res-
nance imaging (DCE-MRI), positron emission tomography
PET), and more  recently, B-mode and Doppler ultrasound (US).
ith varied types of cancer, there is no general agreement
s to which established imaging method is most suitable for
etermining features of tumor blood vessels [1].
Breast DCE-MRI has emerged as the most sensitive tech-
ique for the detection and diagnosis of breast lesions and
umerous studies have confirmed the superior performance
f MRI  compared with mammography and ultrasound (US),
eading to its recommendation for several indications, such
s in the surveillance of women with high risk of breast
ancer and in the clinical workup of patients with carci-
oma unknown primary (CUP) syndrome [2,3]. Moreover, MRI
howed advantages over conventional imaging modalities in
onitoring the tumor response to neoadjuvant treatments [4],
lso because of its capability to detect changes in vascularity
ue to chemotherapeutic agents, including anti-angiogenics
5,6]. MRI  has the potential to tailor surgical planning of
atients with breast cancer, although its impact on clinical
utcomes is still on debate. In addition, some reports suggest
hat preoperative breast MRI  in women with newly diagnosed
ancer could potentially increase the rate of unnecessary biop-
ies and surgery [2]. Recent studies aimed to increase the
pecificity of breast DCE-MRI by adding a vessel analysis to the
tandard morphologic and kinetic criteria, therefore explor-
ng the diagnostic value of vascularity [7–9]. During the past
ecade, this research issue has been approached in two ways:
rst, whole-breast vascularity, and second, local vascularity,
hat is, vessels adjacent to and feeding a lesion or lesions
9]. The evaluation of this information is already allowed,
ince the visualization of bilateral vascular maps is intrinsi-
ally integrated into a standard breast DCE-MRI study without
n increase in acquisition time or the administration ofadditional contrast material [9,10]. However, vascularity is not
usually considered by radiologists, mainly because evaluating
and counting vessels using multiple views may be time con-
suming and a standardized quantification method of breast
vessels does not exist [10]. Several studies have tried to address
the automatic detection and extraction of the breast vascu-
larity to improve the work-flow of radiologists [1,11,12], but
only one of them has been conceived to work on DCE-MRI [13].
However, the last method, proposed by Lin et al. and based on
wavelet transform and the Hessian matrix, is affected by some
limitations. Indeed, it relies on a preliminary manual interac-
tion while breast lesions are excluded by placing a square box
over the lesion, and it has been tested on patients with rela-
tively large lesions, large vessels, and no motion artifacts on
subtracted images. Regarding the evaluation of the vascular-
ity in the clinical practice, the unique quantitative approach
existing has been introduced by Sardanelli et al. [7] and it is
based on the number of vessels per breast, with length of
30 mm or greater and maximal transverse diameter of 2 mm or
greater. This method was used by a recent study [10] to assess
the variation in whole-breast vascular maps on DCE-MRI after
anthracycline- and taxane-based neoadjuvant chemotherapy
(NAC) in patients with locally advanced breast cancer (LABC),
showing a correlation between changes in breast vascular
maps and pathologic tumor response. However, the authors
highlight some limitations of the Sardanelli score system, as
also recognized by other authors [14], such as difficulties in
counting branching vessels, and time-consuming procedure
to define if a vessel should or should not be counted. The
development of a highly reproducible method to extract vas-
cular maps and to quantify vessels within the breast has been
therefore encouraged [9,10]. In 2012, our group developed a
novel fully automatic Hessian-matrix method able to over-
come the limitations of Lin et al. approach [15]. The aim of
the present study is to test the application of our recently
published method to reproducibly quantify breast vascular-
ity, and to evaluate if the vascular volume of cancer-bearing
breast, calculated from automatic vascular maps (AVMs), may
correlate with pathologic tumor response after NAC.
2.  Methods
The dataset was composed by 24 patients (mean age, 46
years; range 31–61) with unilateral LABC diagnosed at mam-
mography and/or ultrasound. For each patient, DCE-MRI was
performed before NAC initiation and repeated after the last
NAC cycle. Breast surgery was scheduled within 3–4 weeks
after the last NAC cycle. After surgery, the histopathologic
response was evaluated using a 5-point assessment scale,
from grade 1 (some alterations to individual malignant cells
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but no reduction in overall numbers compared with the pre-
treatment core biopsy) to grade 5 (pCR; pathologic complete
response) [16]. In the current study, the patients were classi-
fied as responders if the pathologic tumor response to primary
chemotherapy was grade 4 or 5 and as non-responders if the
grade of response ranged between 1 and 3.
DCE-MRI was performed using a 1.5-T scanner (Signa
Excite Hdx, GE Healthcare) with a dedicated 8-channel coil
with the patient in prone position. A 3D gradient-echo axial
sequence (Vibrant, GE Healthcare) was performed with the
following technical parameters: TE in phase; TR/TE, 5.4/2.6;
flip angle, 15◦; slice thickness, 2.6 mm;  matrix, 416 × 416; field
of view, according to the breast volume; and temporal res-
olution, 60–90 s depending on the volume of the breasts.
The sequence was performed before and four times continu-
ously after contrast material administration; a late acquisition
was obtained at 8 min  after contrast material administration.
The contrast-enhanced study started simultaneously with
the bolus injection of 0.1 mmol/kg gadopentetate dimeglu-
mine (Magnevist, Bayer Pharma) at a rate of 2 mL/s, followed
by a saline flush of 20 mL  at the same injection rate. The
Local Ethics Committee approved the retrospective use of the
database for scientific purposes and waived off informed con-
sent. The study was conducted in accordance with national
legislation and the Declaration of Helsinki.
Breast AVMs were extracted by the application of a fully
automatic multiscale 3D Hessian matrix-based algorithm for
vessel detection in breast DCE-MRI [15]. This algorithm is
conceived as a 2-step process to search for geometrical tube-
like structures (Fig. 1), starting from the isotropic subtraction
images. In particular, in order to obtain the best “angiographic
effect” for both arteries and veins [7], the subtraction was
performed between the first enhanced frame and the unen-
hanced frame.
The first step, aiming to detect linear structures, is com-
posed of a multi-scale analysis, and successive volume
integration, while in the second step non-vessel detected vox-
els are reduced according to the analysis of the covariance
matrix.
2.1.  First  step:  multi-scale  analysis
To extract vessels of different dimensions, a measurement
scale which varies within a set range was introduced by apply-
ing a Gaussian blur filter using 5 different standard deviations
(), so that 5 subimages smoothed with increasing  size were
obtained. Since the  of Gaussian blur and vessel dimension




the  values ranged from 0.80 (0) to 1.00 (4), within a step of
0.05, allowing to extract vessels of diameter >1 mm.  In order
to enhance and extract vessels on each smoothed image,  the
morphology of curvilinear structures was assessed via eigen-
value analysis of the Hessian matrix. After setting all positive
eigenvalues to zero, the smallest eigenvalue was subtracted
from the largest eigenvalue, allowing to distinguish linear
structures, which have positive values, from nodular struc-
tures, having values that approximate zero [13,18]. For a fair b i o m e d i c i n e 1 1 7 ( 2 0 1 4 ) 482–488
comparison of images at multiple scales, for each scale the
obtained subimage was multiplied by the respective  value
(normalization).
2.2.  First  step:  volume  integration
To integrate information from the multi-scale analysis, the
maximum intensity projection (MIP) of the five subimages was
performed. To compensate for the dependence on the breast,
vessels and lesion extension of a cumulative histogram based
threshold, the obtained MIP was dichotomized according to a
threshold automatically calculated from the mammary vessel
region. A suitable ROI of a fixed size (50 mm × 100 mm)  was
automatically selected in the region of mammary  vessels of
the MIP  according to Vignati et al. [19] method, and 99% of the
cumulative histogram of the ROI was chosen as the threshold
to extract vessel-like structures.
2.3.  Second  step:  reduction  of  the  number  of
non-vessel  detected  voxels
The binary mask obtained at the end of the first step still
contained some non-vessel structures, such as noise compo-
nents and irregular margins of lesions. These regions have
a blob-like structure with an elongated shape, characterized
by positive values when minimum Hessian eigenvalues are
subtracted from maximum Hessian eigenvalues. The covari-
ance matrix was studied as a morphological descriptor of a
region in terms of the extension along its principal compo-
nent. For each voxel defined as a vessel by the first step,
the covariance was evaluated in an 8 mm-radius volume of
interest. The eigenvectors of the covariance matrix indicate
the principal direction of the analyzed region, and the eigen-
values represent the variance of the voxel coordinates along
each eigenvector. In this analysis, only the maximum (3) and
minimum (1) eigenvalues of the covariance matrix were con-
sidered, because they make it possible to distinguish between
linear (3 > >1) and elongated blob-like (3 > 1) structures. A
threshold was applied to the ratio between maximum and
minimum eigenvalue, and only objects with ratio >7 were con-
sidered. Finally, objects with an area <10 mm3 were discarded
in order to exclude small isolated structures not connected to
other vessel voxels (morphological filter).
The algorithm provides a 3D vascular map  automatically
excluding the lesions. By multiplying each vascular map  voxel
by its volume, the automatic vessel detection method was
used to calculate the vessel volume before the initiation and
after the last NAC cycle for each breast. For breasts harbor-
ing the cancer, the difference in vascular volume before and
after neoadjuvant treatment was compared in responders and
non-responders using the Wilcoxon two-sample test.
A radiologist with 7 years of experience with breast MRI,
blinded to final pathologic analysis, evaluated the breast vas-
cularity on the subtracted images. For each examination, in
both breasts, length and diameter of vessels were manually
measured using electronic calipers, and a vascular score per
breast was assigned. Four grades of breast vascularity were
defined, ranging from 0 to 3, according to the number of
vessels that were 30 mm or greater in length and 2 mm or
greater in maximal transverse diameter. Subsequently, the


































wFig. 1 – Pipeline of the v
adiologist was asked to re-evaluate the breast vascular maps
nd re-assign the vascular score per breast, with the support
f the simultaneous visualization of the AVMs produced by
he algorithm. The results of both evaluations were compared
n terms of mean number of vessels and mean vascular score
er breast, before and after NAC. The mean number of vessels
nd the mean vascular score after NAC were also compared in
esponders and non-responders. The groups were compared
y use of Wilcoxon two sample test. The radiologist further
nalyzed the images of patients in which the two evaluations
ecorded a different number of vessels. For all the analysis, the
tatistical significance level was set at 0.05.
.  Results
ight patients were classified as responders: four with grade
 response (pCR), and four with grade 4 response. For breasts
arboring the cancer, considering both responders and non-
esponders, the median value of the difference in vascular
olume before and after neoadjuvant treatment was 1.01 cc
1st–3rd quartiles 0.27–1.47 cc), while in the contralateral
reasts it was 0.09 cc (1st–3rd quartiles −0.05 to 0.46 cc).
Both vascular evaluations performed by the radiologist,
ith and without support of the AVMs, show a significant
eduction (p < 0.05) of the number of vessels and vascular score
fter NAC for breasts bearing cancer in respect to contralateral
reasts. In Table 1 are reported the values of volume difference,
ifference of number of vessels, and vascular score difference
fter NAC for cancer bearing breasts divided in responders and
on-responders, for both evaluations (with and without the
upport of the automatic maps).
Considering the number of vessels and the vascular score
efore NAC or after NAC, no significant difference was found in
he evaluation performed without support of the AVMs, while
ignificant difference was found according to the evaluation
upported by the AVMs.
The analysis of cases in which the number of vessels
as different between the two evaluations stated that thel extraction algorithm.
automatic vascular mapping helps in correctly detect breast
vessels according to the diameter, especially near the end of
a vascular tree or when a low intensity may complicate the
evaluation.
Figs. 2 and 3 show the MIP  of the subtraction image  and the
AVMs before and after NAC, respectively for a responder and
a non-responder patient.
4.  Discussion
The added diagnostic value of local and global breast vas-
cularity has been recently investigated [9] and preliminary
results have shown that breast vascular maps obtained by
DCE-MRI can be considered as a new approach to evalu-
ate the tumor response after NAC [10]. However, all studies
in this realm highlight the requirement of further improve-
ments for a higher reproducibility of vessel analysis. This
study proposed the application of a validated vessel extraction
algorithm [15] as a standardized quantification tool for breast
vessel quantification, overcoming limitations of the only exist-
ing vessel score system [7], based on human visual analysis.
In particular, since vessels should pass a lower threshold
in length and diameter, in order to be counted, Sardanelli
system could categorize with the same score two breasts
with the same number of vessels, but markedly different
vessels extensions. The proposed method allows calculat-
ing the vascular volume per breast, therefore considering
the real extension of vessels. Considering that the present
study is still ongoing, preliminary results show evidence of
a difference between responders and non-responders in the
vessel volume reduction of cancer-bearing breast after NAC
(median value of volume difference for responders = 1.71 cc;
for non-responders = 0.41 cc; p = 0.003), and therefore suggest
a possible correlation between vessel volume reduction after
NAC and pathologic tumor response.
The translation of the method into clinical practice was
also considered. The radiologist established that the simulta-
neous visualization of AVMs during vascularity analysis allows
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Table 1 – Difference in volume, number of vessels and vascular score after neoadjuvant chemotherapy for vascularity
evaluations with automatic vascular mapping (AVM) and without (no AVM), for responders (resp) and non-responders
(non-resp). p-values were  calculated using the two-sample Wilcoxon test; significant threshold was set at p < 0.05.
Volume (cc), mediana No. vessels, mean ± SD Vascular score, mean ± SD
resp non-resp p resp non-resp p resp non-resp p
No AVM – – – 2.0 ± 1.7 0.9 ± 1.5 0.14 0.8 ± 0.9 0.6 ± 0.9 0.90
 1.2 AVM 1.71 (1.32–2.13) 0.41 (0.20–1.21) 0.003 2.5 ±
a Numbers in parentheses are interquartile ranges.
a more  precise decision if the vessel should or should not
be counted. The reduction of number of vessels and vascular
score after NAC for breasts harboring the cancer showed a sig-
nificant difference between responders and non-responders,
when the evaluation was supported by the automatic map-
ping.
A few limitations of this study should be addressed. The
dataset is limited, and results should be confirmed by a larger
study. The automatic method still incorrectly detects some
artifacts, and a proper improvement of the reduction of the
number of non-vessel detected voxels should be considered.
In order to represent a new biomarker for monitoring the
response to neoadjuvant treatments in a clinical setting, a cut-
off value in the vessel volume reduction should be defined,
Fig. 2 – A 29 years old woman with a locally advanced cancer (HE
external quadrant of the left breast (pointed by arrow) and achie
treatment. Maximum Intensity Projection (MIP) of the subtracted
neoadjuvant chemotherapy (NAC), and MIP  of the subtracted ima0.9 ± 1.7 0.03 1.5 ± 0.5 0.6 ± 1.0 0.02
able to reliably distinguish responders from non-responders
patients. However, this was beyond the scope of the current
retrospective study.
The evaluation of correlation of changes in vascularity with
pathologic tumor response after NAC was proposed as an
application of our previously published method to automat-
ically extract breast vascular maps from DCE-MRI [15], but
other purposes may be envisaged. In the era of targeted cancer
therapy, in fact, there is a growing clinical interest in quantita-
tive methods to evaluate the effects of anti-angiogenic drugs.
Moreover, the extraction of AVMs may be integrated into Com-
puter Aided Diagnosis (CAD) systems, aiming to reduce the
labeling of vessels as suspicious regions, thus improving CAD
specificity.
R-2 Type Invasive Ductal Carcinoma) on the superior
ving pathologic complete response at the end of the
 image (A) and automatic vascular map  (AVM) (B) before
ge (C) and AVM (D) after NAC.
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Fig. 3 – A 45 years old woman with a locally advanced cancer (Luminal B Invasive Ductal Carcinoma) between the internal
quadrants of the left breast (pointed by arrow) with stable disease after neoadjuvant chemotherapy (NAC). Maximum
Intensity Projection (MIP) of the subtracted image (A) and automatic vascular map  (AVM) (B) before NAC, and MIP  of the







mIn conclusion, these encouraging results validate the use
f an automatic multiscale 3D Hessian matrix-based algo-
ithm for vessel detection in breast DCE-MRI. Moreover,
hese preliminary findings suggest the use of AVMs as new
iomarker to evaluate the pathologic response after NAC,
ut AVMs may also find application in other breast DCE-MRI
essel analysis that are waiting for a reliable quantification
ethod.5.  Conclusions
The application of a validated algorithm for automatic ves-
sel extraction on DCE-MRI of the breast is proposed to support
breast vascularity evaluation, recently investigated as a poten-
tial DCE-MRI descriptor correlated with cancer diagnosis and
with the effect of NAC. In particular, the method provides a
 s i n
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standardized vascular mapping, its quantification based on
vessel volume, overcoming the low reproducibility of cur-
rent approaches based on human visual assessment. Taking
into account the preliminary nature of the results here pre-
sented, the vessel volume difference of cancer-bearing breast
after NAC demonstrated a correlation with pathologic tumor
response.
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